Vol. 44.Issue. 3. April 2020 | Actas Urológicas Españolas (English Edition)

ISSN: 2173-5786

Actas Urológicas Españolas is an international journal dedicated to urological diseases and renal transplant. It has been the official publication of the Spanish Urology Association since 1974 and of the American Urology Confederation since 2008. Its articles cover all aspects related to urology. Actas Urológicas Españolas, governed by the peer review system (double blinded), is published online in Spanish and English. Consequently, manuscripts may be sent in Spanish or English and bidirectional free cost translation will be provided. It has high visibility and accessibility and is found in the most important data bases, Medline/Pubmed, Emabase, JCR, Ïndice Médico Español, Índice bibliográfico Español en Ciencias de la Salud (IBECS), Cuiden, Dialnet, Hinari, Scopus, Google Scholar.

See more Open Access Option

Indexed in:

Science Citation Index Expanded, Journal of Citation Reports, Index Medicus/MEDLINE, Scopus, EMBASE/Excerpta Medica, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

1.1

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

1.6

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.308

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.397

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 44. Issue 3.

Pages 125-206 (April 2020)

Editorial

Update of the Andalusian Association of Urology protocol for the management of metastatic castration-resistant prostate cancer

J.L. Álvarez-Ossorio, J.M. Cozar-Olmo, Á. Juárez-Soto, R. Medina-López, J. Moreno-Jiménez, M.J. Requena-Tapia

Actas Urol Esp. 2020;44:125-30

Review articles

The relationship between inguinal hernia and minimally-invasive surgery for prostate cancer: A systematic review of the literature

R. Bertolo, M.C. Mir Maresma, P. Bove, J. Rubio-Briones, M. Ramírez-Backhaus

Actas Urol Esp. 2020;44:131-8

Liquid biopsy and prostate cancer. Current evidence applied to clinical practice

I. Puche-Sanz, A. Rodríguez-Martínez, M.C. Garrido-Navas, I. Robles-Fernández, F. Vázquez-Alonso, M.J. Álvarez Cubero, J.A. Lorente-Acosta, M.J. Serrano-Fernández, J.M. Cózar-Olmo

Actas Urol Esp. 2020;44:139-47

Magnetic resonance as imaging diagnostic tool in prostate cancer: New evidences-The EAU section of uro-technology position

M. Álvarez-Maestro, J. Gómez Rivas, J. Quesada Olarte, D. Carrión Monsalve, C. Trelles Guzman, C. Ballesteros, L.M. Quintana, A. Aguilera Bazán, ... E. Barret

Actas Urol Esp. 2020;44:148-55

Original articles

Androgen deprivation therapy in patients with localized disease: Comparison with curative intent treatments and time to castration resistance. Results of the Spanish Prostate Cancer Registry

J. Garcia-Rodriguez, J.M. Fernandez-Gomez, J.M. Cozar, B. Miñana, F. Gomez-Veiga, A. Rodriguez-Antolin

Actas Urol Esp. 2020;44:156-63

Role of the neutrophil/lymphocyte ratio in patients with metastatic castration-resistant prostate cancer treated first-line with abiraterone

D. Nieblas-Toscano, A.J. Arenas-Bonilla, J.F. Flores-Martín, F. Gutiérrez-Tejero, C. Velarde-Muñoz, C.I. Ramos-Alaminos, M.C. Salas-Moreno, R. Galisteo-Moya, J. Moreno-Jiménez

Actas Urol Esp. 2020;44:164-71

Whole and hemi-gland cryoablation for primary localized prostate cancer: Short and medium-term oncological and functional outcomes

R. Boissier, F. Sanguedolce, A. Territo, D. Vanacore, C. Martinez, F. Regis, A. Gallioli, A. Mercade, ... A. Breda

Actas Urol Esp. 2020;44:172-8

Oncologic outcomes in 408 consecutive patient cohort treated with da Vinci robot-assisted radical prostatectomy

J. Moreno-Sierra, M.I. Galante-Romo, J.L. Senovilla-Perez, E. Redondo-González, I. Galindo-Herrero, J. Barrera-Ortega, R. Vives-Dilmes, J. Ariño-Irujo, ... C. Fernández-Perez

Actas Urol Esp. 2020;44:179-86

The impact of time from biopsy to radical prostatectomy on Gleason score undergrading and other related factors

A.J. Virseda Rodríguez, S. Marcos Asensio, M. Herrero Polo, T. Hernández Sanchez, A. Sanz Ruiz, F. García, F. Vesga, E. Gutiérrez, ... F. Gómez Veiga

Actas Urol Esp. 2020;44:187-95

Complications of transrectal prostate biopsy in our context. International multicenter study of 3350 patients

M. Perán Teruel, M.F. Lorenzo-Gómez, N. Veiga Canuto, B.Y. Padilla-Fernández, L.S. Valverde-Martínez, F. Migliorini, B. Jorge Pereira, H.M. Pires Coelho, J.M. Osca García

Actas Urol Esp. 2020;44:196-204

Letter to the editor

Regarding androgen deprivation therapy, we must use the correct Spanish translation for deprivation, privación; not the anglicism deprivación

J. Muñoz-Rodríguez, A. Domínguez

Actas Urol Esp. 2020;44:205-6

Indexed in:

Follow us:

Subscribe:

Subscribe to our newsletter